Clinical Trial Update: Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the glycemic effects of CKD-501 in adults with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CKD-501

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED